Regulatory Considerations on the Development, Evaluation, and Approval of Therapies in Rheumatoid Arthritis Prevention.

Regulatory Considerations on the Development, Evaluation, and Approval of Therapies in Rheumatoid Arthritis Prevention. Clin Ther. 2019 Jun 12;: Authors: Richard C, Hedrick JA PMID: 31202507 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31202507?dopt=Abstract

Source: Clinical Therapeutics - June 11, 2019 Category: Drugs & Pharmacology Authors: Richard C, Hedrick JA Tags: Clin Ther Source Type: research

More News: Arthritis | Drugs & Pharmacology | Rheumatoid Arthritis | Rheumatology | Science